264 related articles for article (PubMed ID: 8649611)
1. Intramuscular use of fosphenytoin: an overview.
Uthman BM; Wilder BJ; Ramsay RE
Neurology; 1996 Jun; 46(6 Suppl 1):S24-8. PubMed ID: 8649611
[TBL] [Abstract][Full Text] [Related]
2. Intramuscular fosphenytoin (Cerebyx) in patients requiring a loading dose of phenytoin.
Ramsay RE; Wilder BJ; Uthman BM; Garnett WR; Pellock JM; Barkley GL; Leppik IE; Knapp LE
Epilepsy Res; 1997 Oct; 28(3):181-7. PubMed ID: 9332883
[TBL] [Abstract][Full Text] [Related]
3. Intravenous administration of fosphenytoin: options for the management of seizures.
Ramsay RE; DeToledo J
Neurology; 1996 Jun; 46(6 Suppl 1):S17-9. PubMed ID: 8649609
[TBL] [Abstract][Full Text] [Related]
4. The safety, tolerability, and pharmacokinetics of fosphenytoin after intramuscular and intravenous administration in neurosurgery patients.
Boucher BA; Feler CA; Dean JC; Michie DD; Tipton BK; Smith KR; Kramer RE; Young B; Parks BR; Kugler AR
Pharmacotherapy; 1996; 16(4):638-45. PubMed ID: 8840370
[TBL] [Abstract][Full Text] [Related]
5. Clinical experience with fosphenytoin in adults: pharmacokinetics, safety, and efficacy.
Knapp LE; Kugler AR
J Child Neurol; 1998 Oct; 13 Suppl 1():S15-8; discussion S30-2. PubMed ID: 9796747
[TBL] [Abstract][Full Text] [Related]
6. The safety and efficacy of fosphenytoin for the treatment of status epilepticus.
Popławska M; Borowicz KK; Czuczwar SJ
Expert Rev Neurother; 2015; 15(9):983-92. PubMed ID: 26289487
[TBL] [Abstract][Full Text] [Related]
7. Fosphenytoin: clinical pharmacokinetics and comparative advantages in the acute treatment of seizures.
Fischer JH; Patel TV; Fischer PA
Clin Pharmacokinet; 2003; 42(1):33-58. PubMed ID: 12489978
[TBL] [Abstract][Full Text] [Related]
8. Safety and tolerance of multiple doses of intramuscular fosphenytoin substituted for oral phenytoin in epilepsy or neurosurgery.
Wilder BJ; Campbell K; Ramsay RE; Garnett WR; Pellock JM; Henkin SA; Kugler AR
Arch Neurol; 1996 Aug; 53(8):764-8. PubMed ID: 8759983
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and clinical effects of phenytoin and fosphenytoin in children with severe malaria and status epilepticus.
Ogutu BR; Newton CR; Muchohi SN; Otieno GO; Edwards G; Watkins WM; Kokwaro GO
Br J Clin Pharmacol; 2003 Jul; 56(1):112-9. PubMed ID: 12848783
[TBL] [Abstract][Full Text] [Related]
10. Safety of fosphenytoin sodium.
Fierro LS; Savulich DH; Benezra DA
Am J Health Syst Pharm; 1996 Nov; 53(22):2707-12. PubMed ID: 8931812
[TBL] [Abstract][Full Text] [Related]
11. Pharmacology and pharmacokinetics of fosphenytoin.
Browne TR; Kugler AR; Eldon MA
Neurology; 1996 Jun; 46(6 Suppl 1):S3-7. PubMed ID: 8649612
[TBL] [Abstract][Full Text] [Related]
12. Fosphenytoin use in children.
Pellock JM
Neurology; 1996 Jun; 46(6 Suppl 1):S14-6. PubMed ID: 8649608
[TBL] [Abstract][Full Text] [Related]
13. Fosphenytoin and phenytoin in patients with status epilepticus: improved tolerability versus increased costs.
DeToledo JC; Ramsay RE
Drug Saf; 2000 Jun; 22(6):459-66. PubMed ID: 10877039
[TBL] [Abstract][Full Text] [Related]
14. Effects of fosphenytoin on nerve agent-induced status epilepticus.
McDonough JH; Benjamin A; McMonagle JD; Rowland T; Shih TM
Drug Chem Toxicol; 2004 Feb; 27(1):27-39. PubMed ID: 15038246
[TBL] [Abstract][Full Text] [Related]
15. Fosphenytoin in infants.
Takeoka M; Krishnamoorthy KS; Soman TB; Caviness VS
J Child Neurol; 1998 Nov; 13(11):537-40. PubMed ID: 9853645
[TBL] [Abstract][Full Text] [Related]
16. New anticonvulsant drugs. Focus on flunarizine, fosphenytoin, midazolam and stiripentol.
Bebin M; Bleck TP
Drugs; 1994 Aug; 48(2):153-71. PubMed ID: 7527321
[TBL] [Abstract][Full Text] [Related]
17. Pediatric use of intravenous and intramuscular phenytoin: lessons learned.
Wheless JW
J Child Neurol; 1998 Oct; 13 Suppl 1():S11-4; discussion S30-2. PubMed ID: 9796746
[TBL] [Abstract][Full Text] [Related]
18. Randomized evaluation of adverse events and length-of-stay with routine emergency department use of phenytoin or fosphenytoin.
Coplin WM; Rhoney DH; Rebuck JA; Clements EA; Cochran MS; O'Neil BJ
Neurol Res; 2002 Dec; 24(8):842-8. PubMed ID: 12500711
[TBL] [Abstract][Full Text] [Related]
19. Efficacy, Tolerability and Serum Phenytoin Levels after Intravenous Fosphenytoin Loading Dose in Children with Status Epilepticus.
Srivastava K; Bhartiya S; Gavli V; Patil R; Rajadhyaksha S
Indian Pediatr; 2020 Mar; 57(3):218-221. PubMed ID: 32198860
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of intramuscular fosphenytoin vs intravenous phenytoin loading in the ED.
Aaronson PM; Belgado BS; Spillane JP; Kunisaki TA
Am J Emerg Med; 2011 Nov; 29(9):983-8. PubMed ID: 20685063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
